Evaluation of the performance and safety of adding the iron chelator MEX-CD1 to dialysate during continuous veno-venous haemodialysis for removing excess labile iron in intensive care patients with sepsis-associated acute kidney injury - the Iron in
Authors
A. Couturier (ORCID: https://orcid.org/0000-0002-3752-8533)
Chris Serrand (ORCID: https://orcid.org/0000-0002-6074-8577)
Evaluation of the performance and safety of adding the iron chelator MEX-CD1 to dialysate during continuous veno-venous haemodialysis for removing excess labile iron in intensive care patients with sepsis-associated acute kidney injury - the Iron in
A. Couturier, Chris Serrand, B. Allaouchiche, Saber Davide Barbar et al.
Journal
BMJ Open
Topics
Acute Kidney Injury Research
article
Evaluation of the performance and safety of adding the iron chelator MEX-CD1 to dialysate during continuous veno-venous haemodialysis for removing excess labile iron in intensive care patients with sepsis-associated acute kidney injury - the Iron in
A. Couturier, Chris Serrand, B. Allaouchiche, Saber Davide Barbar, Olivier Tillement, Jean-Yves Lefrant, Christophe Masseguin
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(12)
Institutions
Université Claude Bernard Lyon 1 (FR), Hôpital américain de paris (FR), Centre National de la Recherche Scientifique (FR), Hospices Civils de Lyon (FR), VetAgro Sup (FR), Université de Nîmes (FR)